Literature DB >> 22135512

Challenges in the management of nasopharyngeal carcinoma: a review.

Baharudin Abdullah1, Azila Alias, Shahid Hassan.   

Abstract

Nasopharyngeal carcinoma (NPC) is a non-lymphomatous, squamous cell carcinoma that occurs in the epithelial lining of the nasopharynx, an area that shows varying degrees of differentiation. Although relatively rare worldwide, NPC has substantial incidence and mortality in populations in Southeast Asia and in people with Southern Chinese ancestry. In Malaysia, NPC is a leading cancer type. In the clinic, NPC presents on a very wide spectrum. Therefore, a high degree of suspicion on the part of the clinician and an increased awareness by the patient is essential for the recognition of an early lesion. Early detection of the cancer is important as it affects the patient's prognosis and the mode of treatment. Managing patients with NPC is very challenging as patients usually present late when the cancer is already in an advanced stage. Here, we review the challenges in the management of NPC.

Entities:  

Keywords:  challenges; management; medical sciences; nasopharyngeal carcinoma

Year:  2009        PMID: 22135512      PMCID: PMC3216136     

Source DB:  PubMed          Journal:  Malays J Med Sci        ISSN: 1394-195X


  22 in total

1.  Serum and salivary IgA antibodies against a defined epitope of the Epstein-Barr virus nuclear antigen (EBNA) are elevated in nasopharyngeal carcinoma.

Authors:  Y T Foong; H M Cheng; C K Sam; J Dillner; W Hinderer; U Prasad
Journal:  Int J Cancer       Date:  1990-06-15       Impact factor: 7.396

2.  Screening nasopharyngeal carcinoma by detection of the latent membrane protein 1 (LMP-1) gene with nasopharyngeal swabs.

Authors:  Sheng-Po Hao; Ngan-Ming Tsang; Kai-Ping Chang
Journal:  Cancer       Date:  2003-04-15       Impact factor: 6.860

3.  Aids to diagnosis of nasopharyngeal carcinoma.

Authors:  P Umapati; P Rajadurai; S C Kook; R Lekhraj; J Singh
Journal:  Med J Malaysia       Date:  1988-06

4.  Antibodies to Epstein-Barr virus in patients with nasopharyngeal carcinoma and in comparison groups.

Authors:  H B Neel; G R Pearson; W F Taylor
Journal:  Ann Otol Rhinol Laryngol       Date:  1984 Sep-Oct       Impact factor: 1.547

5.  Comparison of AJCC 1988 and 1997 classifications for nasopharyngeal carcinoma. American Joint Committee on Cancer.

Authors:  E Ozyar; F Yildiz; F H Akyol; I L Atahan
Journal:  Int J Radiat Oncol Biol Phys       Date:  1999-07-15       Impact factor: 7.038

6.  Epstein-Barr viral DNA in serum of patients with nasopharyngeal carcinoma.

Authors:  A Mutirangura; W Pornthanakasem; A Theamboonlers; V Sriuranpong; P Lertsanguansinchi; S Yenrudi; N Voravud; P Supiyaphun; Y Poovorawan
Journal:  Clin Cancer Res       Date:  1998-03       Impact factor: 12.531

7.  Health-related quality of life for nasopharyngeal carcinoma patients with cancer-free survival after treatment.

Authors:  Fu-Min Fang; Herng-Chia Chiu; Wen-Rei Kuo; Chong-Jong Wang; Stephen W Leung; Hui-Chun Chen; Li-Min Sun; Hsuan-Chih Hsu
Journal:  Int J Radiat Oncol Biol Phys       Date:  2002-07-15       Impact factor: 7.038

Review 8.  Retrospective analysis of patients with nasopharyngeal carcinoma treated during 1976-1985: survival after local recurrence.

Authors:  A W Lee; S C Law; W Foo; Y F Poon; F K Cheung; D K Chan; S Y Tung; M Thaw; J H Ho
Journal:  Int J Radiat Oncol Biol Phys       Date:  1993-08-01       Impact factor: 7.038

9.  The effect of primary tumor volumes in advanced T-staged nasopharyngeal tumors.

Authors:  Cheng-Chuan Chang; Mu-Kuan Chen; Mu-Tai Liu; Hwa-Koon Wu
Journal:  Head Neck       Date:  2002-10       Impact factor: 3.147

10.  Serum IgA cross-reactivity between glycine-alanine repeat sequence of EBNA-1 and keratin or collagen in nasopharyngeal carcinoma.

Authors:  A Mathew; H M Cheng; C K Sam; U Prasad
Journal:  Clin Immunol Immunopathol       Date:  1994-05
View more
  10 in total

1.  Nasopharyngeal Carcinoma in Oman and Malaysia: Is There Any Difference?

Authors:  Irfan Mohamad; Sanjeevan Nadarajah
Journal:  Oman Med J       Date:  2015-09

2.  The Incidence of Nasopharyngeal Carcinoma in Pahang State of Malaysia from 2012 to 2017.

Authors:  Azmir Ahmad; Wardah Mohd Yassin; Nor Azlina A Rahman; Wan Ishlah Leman; Luqman Rosla; Mark Paul; Sharifah Nor Ezura Syed Yussof; Kamariah Mohamed Awang; Kahairi Abdullah; Mohd Arifin Kaderi
Journal:  Malays J Med Sci       Date:  2021-02-24

3.  Upright epiglottis prevents aspiration in patients with nasopharyngeal carcinoma post-chemoradiation.

Authors:  Susyana Tamin; Marlinda Adham; Arfan Noer; Nana Supriana; Saptawati Bardosono
Journal:  PLoS One       Date:  2021-12-09       Impact factor: 3.240

Review 4.  Functional Roles of JNK and p38 MAPK Signaling in Nasopharyngeal Carcinoma.

Authors:  Lesley Jia Wei Pua; Chun-Wai Mai; Felicia Fei-Lei Chung; Alan Soo-Beng Khoo; Chee-Onn Leong; Wei-Meng Lim; Ling-Wei Hii
Journal:  Int J Mol Sci       Date:  2022-01-20       Impact factor: 5.923

Review 5.  Present Status, Challenges, and Prospects of Dihydromyricetin in the Battle against Cancer.

Authors:  Jiajun Wu; Zuowei Xiao; Hongfang Li; Neng Zhu; Jia Gu; Wenmao Wang; Chao Liu; Wei Wang; Li Qin
Journal:  Cancers (Basel)       Date:  2022-07-18       Impact factor: 6.575

6.  MiR-124 suppresses tumor growth and metastasis by targeting Foxq1 in nasopharyngeal carcinoma.

Authors:  Xiao Hong Peng; Hao Ran Huang; Juan Lu; Xiong Liu; Fei Peng Zhao; Bao Zhang; Shao Xiong Lin; Lu Wang; Huai Hong Chen; Xia Xu; Fan Wang; Xiang Ping Li
Journal:  Mol Cancer       Date:  2014-08-07       Impact factor: 27.401

7.  Ten years of experience in clinicopathologic characteristics, treatment and outcome of patients with nasopharyngeal pathologies in Yazd, Iran.

Authors:  Fariba Binesh; Ahmad Shajari; Somayeh Abdollahi; Nasim Behniafard
Journal:  Electron Physician       Date:  2016-10-25

8.  Prognostic factors of nasopharyngeal carcinoma patients in a tertiary referral hospital: a retrospective cohort study.

Authors:  Ab Hamid Siti-Azrin; Bachok Norsa'adah; Nyi Nyi Naing
Journal:  BMC Res Notes       Date:  2017-12-06

9.  Low-Dose Aspirin Use Significantly Improves the Survival of Late-stage NPC: A Propensity Score-Matched Cohort Study in Taiwan.

Authors:  Sheng-Dean Luo; Wei-Chih Chen; Ching-Nung Wu; Yao-Hsu Yang; Shau-Hsuan Li; Fu-Min Fang; Tai-Lin Huang; Yu-Ming Wang; Tai-Jan Chiu; Shao-Chun Wu
Journal:  Cancers (Basel)       Date:  2020-06-12       Impact factor: 6.639

10.  LncRNA MEG3 inhibits the development of nasopharyngeal carcinoma by sponging miR-543 targeting KLF4.

Authors:  Jiayu Ning; Liqin Zhang; Hua Guo; Sujuan Zhou; Xiaomei Sun; Weijing Bao
Journal:  Transl Cancer Res       Date:  2020-02       Impact factor: 1.241

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.